Metformin Inhibits Migration and Invasion of Cholangiocarcinoma Cells

BACKGROUND: Metformin is an oral anti-diabetic agent that has been widely prescribed for treatment of type II diabetes. Anti-cancer properties of metformin have been revealed for numerous human malignancies including cholangiocarcinoma (CCA) with anti-proliferative effects in vitro. However, effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Son, Trinh Xuan, Huyen, Nguyen Thi Bich, Saimuang, Kween, Prachayasittikul, Virapong, On, Waraporn Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454745/
https://www.ncbi.nlm.nih.gov/pubmed/28345832
http://dx.doi.org/10.22034/APJCP.2017.18.2.473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454745/
https://www.ncbi.nlm.nih.gov/pubmed/28345832
http://dx.doi.org/10.22034/APJCP.2017.18.2.473

Ejemplares similares